Ebos to buy Australia's HPS for $A154m, expanding pharmacy footprint The acquisition is expected to increase Ebos's underlying ebitda by at least 5% in the 2018 financial year. NBR Contributor Tue, 23 May 2017 EBOSpharmacyhealthcaremedicineChristchurchhospitalPatrick Daviespharmaceuticalsanimal health productsHPS
